Your browser doesn't support javascript.
loading
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Souglakos, J; Boukovinas, I; Kakolyris, S; Xynogalos, S; Ziras, N; Athanasiadis, A; Androulakis, N; Christopoulou, A; Vaslamatzis, M; Ardavanis, A; Emmanouilides, C; Bompolaki, I; Kourousis, C; Makrantonakis, P; Christofyllakis, C; Athanasiadis, E; Kentepozidis, N; Karampeazis, A; Katopodi, U; Anagnosopoulos, A; Papadopoulos, G; Prinarakis, E; Kalisperi, A; Mavroudis, D; Georgoulias, V.
Afiliação
  • Souglakos J; Hellenic Oncology Research Group, Athens, Greece. Electronic address: johnsougl@gmail.com.
  • Boukovinas I; Hellenic Oncology Research Group, Athens, Greece.
  • Kakolyris S; Hellenic Oncology Research Group, Athens, Greece.
  • Xynogalos S; Hellenic Oncology Research Group, Athens, Greece.
  • Ziras N; Hellenic Oncology Research Group, Athens, Greece.
  • Athanasiadis A; Hellenic Oncology Research Group, Athens, Greece.
  • Androulakis N; Hellenic Oncology Research Group, Athens, Greece.
  • Christopoulou A; Hellenic Oncology Research Group, Athens, Greece.
  • Vaslamatzis M; Hellenic Oncology Research Group, Athens, Greece.
  • Ardavanis A; Hellenic Oncology Research Group, Athens, Greece.
  • Emmanouilides C; Hellenic Oncology Research Group, Athens, Greece.
  • Bompolaki I; Hellenic Oncology Research Group, Athens, Greece.
  • Kourousis C; Hellenic Oncology Research Group, Athens, Greece.
  • Makrantonakis P; Hellenic Oncology Research Group, Athens, Greece.
  • Christofyllakis C; Hellenic Oncology Research Group, Athens, Greece.
  • Athanasiadis E; Hellenic Oncology Research Group, Athens, Greece.
  • Kentepozidis N; Hellenic Oncology Research Group, Athens, Greece.
  • Karampeazis A; Hellenic Oncology Research Group, Athens, Greece.
  • Katopodi U; Hellenic Oncology Research Group, Athens, Greece.
  • Anagnosopoulos A; Hellenic Oncology Research Group, Athens, Greece.
  • Papadopoulos G; Hellenic Oncology Research Group, Athens, Greece.
  • Prinarakis E; Hellenic Oncology Research Group, Athens, Greece.
  • Kalisperi A; Hellenic Oncology Research Group, Athens, Greece.
  • Mavroudis D; Hellenic Oncology Research Group, Athens, Greece.
  • Georgoulias V; Hellenic Oncology Research Group, Athens, Greece.
Ann Oncol ; 30(8): 1304-1310, 2019 08 01.
Article em En | MEDLINE | ID: mdl-31228203
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaloacetatos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Capecitabina / Duração da Terapia Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxaloacetatos / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias do Colo / Capecitabina / Duração da Terapia Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article